by AIP Online Bureau | Apr 21, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic
NEW DELHI: The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95). The price for central government stays at Rs 150....
by AIP Online Bureau | Apr 21, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic
New Delhi: The government is likely to waive 10 percent customs duty levied on imported vaccines in a bid to keep low the cost of overseas vaccines that are being eyed to supplement domestically made shots ahead of opening Covid-19 vaccination to all citizens...
by AIP Online Bureau | Apr 21, 2021 | Eco/Invest/Demography, Facts, Health, Pandemic
Israel has registered eight cases of a coronavirus variant first identified in India and believes that the Pfizer/BioNTech vaccine is at least partially effective against it, an Israeli health official said on Tuesday. An initial seven cases of the Indian variant were...
by AIP Online Bureau | Apr 21, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic
London: Britain on Tuesday said it would launch a new international expert group to help bolster the world's preparedness for the next pandemic and expedite the development of vaccines against future diseases when they emerge. Launched under Britain's...
by AIP Online Bureau | Apr 21, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic, Policy, Regulation, Risk Management
London: Pharmaceutical companies making Covid vaccines are largely protected legally in the event of harmful side effects, like blood clots that have been linked to jabs from AstraZeneca and Johnson & Johnson. However while some governments will pay...
